CANCER OF THE THYROID - EXPLORATIONS OF CLINICAL BIOLOGY

被引:0
|
作者
HENNEN, G
机构
关键词
CANCER; THYROID; PAPILLARY; FOLLICULAR; ANAPLASTIC; MEDULLAR; THYROGLOBULIN; THYROCALCITONIN; PARATHORMONE; ACTH; VIP; MEN; 2A; 2B;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
A brief review of the cancers derived from the follicular thyroid epithelium and parafollicular cells (medullar cancer) is made, The contribution of clinical biology to the diagnosis has little significance in the case of thyroid cancer. On the other hand, the quantitative analysis of thyroglobulin is very important for the detection of recurrence in the course of the follow-up of a patient who has been treated by complete thyroidectomy. The biological markers of medullar cancer are most specific. The observation of pathological secretion of thyrocalcitonin is determining for the diagnosis of medullary carcinoma. It must lead to a parathyroid and medullo-adrenal exploration as well as to systematic investigation of family history. These steps are essential for the diagnosis of the syndromes of multiple endocrine neoplasias types 2a and 2b.
引用
收藏
页码:30 / 32
页数:3
相关论文
共 50 条
  • [41] Clinical and Translational Challenges in Thyroid Cancer
    Hernando, Jorge
    Ros, Javier
    Arroyo, Alvaro
    Capdevila, Jaume
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (29) : 4806 - 4822
  • [42] Obesity and Thyroid Cancer: A Clinical Update
    Pappa, Theodora
    Alevizaki, Maria
    THYROID, 2014, 24 (02) : 190 - 199
  • [43] Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
    Moeller, Lars C.
    Fuehrer, Dagmar
    ENDOCRINE-RELATED CANCER, 2013, 20 (02) : R19 - R29
  • [44] Molecular biology of colorectal cancer in clinical practice
    Kit, O. I.
    Vodolazhsky, D. I.
    MOLECULAR BIOLOGY, 2015, 49 (04) : 471 - 479
  • [45] Fucosylation in cancer biology and its clinical applications
    Shan, Ming
    Yang, Dandan
    Dou, Huaiqian
    Zhang, Lijuan
    GLYCANS AND GLYCOSAMINOGLYCANS AS CLINICAL BIOMARKERS AND THERAPEUTICS, PT A, 2019, 162 : 93 - 119
  • [46] CLINICAL RELEVANCE OF LUNG-CANCER BIOLOGY
    CARNEY, DN
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 884 - 885
  • [47] COLORECTAL-CANCER BIOLOGY - CLINICAL IMPLICATIONS
    JOHNSTON, PG
    ALLEGRA, CJ
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 418 - 432
  • [48] Molecular Biology of Lung Cancer: Clinical Implications
    Larsen, Jill E.
    Minna, John D.
    CLINICS IN CHEST MEDICINE, 2011, 32 (04) : 703 - +
  • [49] Clinical applications of gut microbiota in cancer biology
    Wong, Sunny H.
    Kwong, Thomas N. Y.
    Wu, Chun-Ying
    Yu, Jun
    SEMINARS IN CANCER BIOLOGY, 2019, 55 : 28 - 36
  • [50] The Biology and Clinical Development of MEK Inhibitors for Cancer
    Luke, Jason J.
    Ott, Patrick A.
    Shapiro, Geoffrey I.
    DRUGS, 2014, 74 (18) : 2111 - 2128